Rubius Therapeutics RUBY
$ 0.08
-33.55%
Annual report 2022
added 02-27-2023
Country |
USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Pablo Cagnoni |
Employees in the company |
197 |
Shares |
90.3 M |
Market Cap[1] |
$ 7.81 M |
EBITDA (LTM) |
$ -191 M |
P/E (LTM) |
-0.03 |
P/S (LTM) |
- |
EPS (LTM) |
-2.32 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.